AQR CAPITAL MANAGEMENT LLC

Position in ARCT — Arcturus Therapeutics Holdings Inc.

CIK 1167557 Greenwich, CT

Position in ARCT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,536,089

+$3,291,026 QoQ

Shares Held

675,014

+318.5% QoQ

Ownership

2.37%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#10

of 133 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,647,082,401 across 216 Biotechnology names. ARCT ranks #83 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,126,080	$702,155,918
2	INCY	Incyte Corp	5,320,901	$603,177,333
3	EXEL	Exelixis, Inc.	11,023,943	$599,812,735
4	JAZZ	Jazz Pharmaceuticals plc	1,522,568	$366,893,205
5	BMRN	Biomarin Pharmaceutical Inc	5,699,541	$326,127,732
6	VRTX	Vertex Pharmaceuticals Inc / Ma	616,170	$306,070,117
7	RVMD	Revolution Medicines, Inc.	1,295,450	$242,611,869
8	RPRX	Royalty Pharma plc	4,305,412	$241,404,446

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,536,089	675,014	+318.5%	Shares	Defined	2026-08-14
2026-03-31	$1,245,063	161,278	+271.6%	Shares	Other	2026-05-15
2025-12-31	$266,059	43,403	+286.9%	Shares	Other	2026-02-17
2025-06-30	$145,944	11,218	-7.0%	Shares	Other	2025-08-14
2025-03-31	$127,787	12,067	-0.1%	Shares	Other	2025-05-15
2024-09-30	$280,329	12,078	+3.2%	Shares	Other	2024-11-14
2024-06-30	$284,894	11,700	-84.2%	Shares	Other	2024-08-14
2024-03-31	$2,506,578	74,225	-53.6%	Shares	Other	2024-05-15
2023-12-31	$5,040,794	159,873	-7.2%	Shares	Defined	2024-02-14
2023-09-30	$4,399,761	172,202	+239.8%	Shares	Defined	2023-11-14
2023-06-30	$1,453,387	50,676	+325.3%	Shares	Defined	2023-08-14
2020-12-31	$516,829	11,914	-28.9%	Shares	Defined	2021-02-16
2020-09-30	$718,832	16,756	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.